Azithromycin/chloroquine-diphosphateDrug ineffectiveness following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1966卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43540-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：87 / 87

相关论文

共 50 条

[21] DexamethasoneHyperglycaemia following off-label use: case report
Reactions Weekly, 2022, 1896 (1) : 173 - 173
[22] TocilizumabAnaphylaxis following off-label use: case report
Reactions Weekly, 2021, 1865 (1) : 397 - 397
[23] MirtazapineTachyphylaxis following off-label use: case report
Reactions Weekly, 2018, 1703 (1) : 182 - 182
[24] RituximabPancytopenia following off-label use: case report
Reactions Weekly, 2020, 1807 (1) : 176 - 176
[25] DexamethasoneMucormycosis following off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 181 - 181
[26] SintilimabFasciitis following off-label use: case report
Reactions Weekly, 2021, 1884 (1) : 391 - 391
[27] HydroxychloroquineEosinophilia following off-label use: case report
Reactions Weekly, 2021, 1867 (1) : 204 - 204
[28] GlibenclamideHypoglycaemia following an off-label use : case report
Reactions Weekly, 2021, 1866 (1) : 190 - 190
[29] HydroxychloroquineHaemolysis following off-label use: case report
Reactions Weekly, 2021, 1836 (1) : 376 - 376
[30] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2020, 1802 (1) : 114 - 114

← 1 2 3 4 5 →